55
61
Growth Score 55 in past quarter
-16 pts
Heat Score 61 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
246218
Geistlich Pharma North America brings the leader in regenerative dentistry.
- Gudrun Denke: Deputy Director Preclinical and Clinical Research & Development
Urs Iten: CIO / Director Group ITPast Role: Siemens, Director, Global Portfolio Management, Data Centers
About the Company
Geistlich Pharma North America brings the leader in regenerative dentistry directly to the United States and Canada. For 160 years, their respected family-owned Swiss parent company has pioneered technological advances that make regenerative treatment, with safe and naturally sourced biomaterials, the preferred choice for clinical predictability.
